Autologous CD133+ cells for treatment of critical limb ischemia
The aim of this study was to determine the feasibility and safety of treatment fof critical limb ischemia with autologous adult CD133+ stem cells injected into the leg muscles.
Read More
Culture cells were not specified by the originator of this study.
Read More
Product Information for
Autologous CD133+ cells for treatment of critical limb ischemia